A notable advancement in diabetes treatment is emerging with the approval of tirzepatide at a dosage of 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and https://greatbookmarking.com/story21349047/revolutionary-introduction-tirzepatide-strength-for-glucose-control